Logo image of YAR.OL

YARA INTERNATIONAL ASA (YAR.OL) Stock Fundamental Analysis

OSL:YAR - Euronext Oslo - NO0010208051 - Common Stock - Currency: NOK

385  -3.2 (-0.82%)

Fundamental Rating

4

Overall YAR gets a fundamental rating of 4 out of 10. We evaluated YAR against 68 industry peers in the Chemicals industry. YAR has an average financial health and profitability rating. YAR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year YAR was profitable.
In the past year YAR had a positive cash flow from operations.
In the past 5 years YAR has always been profitable.
In the past 5 years YAR always reported a positive cash flow from operatings.
YAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

The Return On Assets of YAR (1.85%) is comparable to the rest of the industry.
With a Return On Equity value of 3.86%, YAR perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.87%, YAR is doing good in the industry, outperforming 72.06% of the companies in the same industry.
YAR had an Average Return On Invested Capital over the past 3 years of 10.26%. This is above the industry average of 6.10%.
Industry RankSector Rank
ROA 1.85%
ROE 3.86%
ROIC 6.87%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
YAR.OL Yearly ROA, ROE, ROICYAR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

YAR's Profit Margin of 2.05% is in line compared to the rest of the industry. YAR outperforms 54.41% of its industry peers.
In the last couple of years the Profit Margin of YAR has declined.
YAR's Operating Margin of 7.91% is fine compared to the rest of the industry. YAR outperforms 66.18% of its industry peers.
YAR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 27.32%, YAR is in line with its industry, outperforming 44.12% of the companies in the same industry.
YAR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.91%
PM (TTM) 2.05%
GM 27.32%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
YAR.OL Yearly Profit, Operating, Gross MarginsYAR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), YAR is creating some value.
YAR has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for YAR has been reduced compared to 5 years ago.
The debt/assets ratio for YAR is higher compared to a year ago.
YAR.OL Yearly Shares OutstandingYAR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
YAR.OL Yearly Total Debt VS Total AssetsYAR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

YAR has an Altman-Z score of 2.75. This is not the best score and indicates that YAR is in the grey zone with still only limited risk for bankruptcy at the moment.
YAR has a better Altman-Z score (2.75) than 69.12% of its industry peers.
YAR has a debt to FCF ratio of 8.76. This is a slightly negative value and a sign of low solvency as YAR would need 8.76 years to pay back of all of its debts.
YAR's Debt to FCF ratio of 8.76 is fine compared to the rest of the industry. YAR outperforms 63.24% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that YAR is somewhat dependend on debt financing.
The Debt to Equity ratio of YAR (0.52) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 8.76
Altman-Z 2.75
ROIC/WACC0.81
WACC8.49%
YAR.OL Yearly LT Debt VS Equity VS FCFYAR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

YAR has a Current Ratio of 1.90. This is a normal value and indicates that YAR is financially healthy and should not expect problems in meeting its short term obligations.
YAR has a Current ratio of 1.90. This is in the better half of the industry: YAR outperforms 60.29% of its industry peers.
YAR has a Quick Ratio of 1.90. This is a bad value and indicates that YAR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.96, YAR is in line with its industry, outperforming 42.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.96
YAR.OL Yearly Current Assets VS Current LiabilitesYAR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 175.00% over the past year.
YAR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.01% yearly.
YAR shows a decrease in Revenue. In the last year, the revenue decreased by -2.88%.
The Revenue has been growing slightly by 1.52% on average over the past years.
EPS 1Y (TTM)175%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%380.95%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%10.55%

3.2 Future

YAR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -11.73% yearly.
The Revenue is expected to grow by 2.71% on average over the next years.
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-11.73%
Revenue Next Year6.33%
Revenue Next 2Y2.5%
Revenue Next 3Y2.43%
Revenue Next 5Y2.71%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
YAR.OL Yearly Revenue VS EstimatesYAR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
YAR.OL Yearly EPS VS EstimatesYAR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

YAR is valuated correctly with a Price/Earnings ratio of 15.10.
YAR's Price/Earnings ratio is a bit cheaper when compared to the industry. YAR is cheaper than 79.41% of the companies in the same industry.
When comparing the Price/Earnings ratio of YAR to the average of the S&P500 Index (27.30), we can say YAR is valued slightly cheaper.
With a Price/Forward Earnings ratio of 12.03, YAR is valued correctly.
Based on the Price/Forward Earnings ratio, YAR is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, YAR is valued a bit cheaper.
Industry RankSector Rank
PE 15.1
Fwd PE 12.03
YAR.OL Price Earnings VS Forward Price EarningsYAR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of YAR indicates a rather cheap valuation: YAR is cheaper than 80.88% of the companies listed in the same industry.
72.06% of the companies in the same industry are more expensive than YAR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.83
EV/EBITDA 6.23
YAR.OL Per share dataYAR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

YAR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as YAR's earnings are expected to grow with 17.28% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y35.44%
EPS Next 3Y17.28%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.33%, YAR has a reasonable but not impressive dividend return.
YAR's Dividend Yield is comparable with the industry average which is at 3.08.
Compared to an average S&P500 Dividend Yield of 2.37, YAR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

The dividend of YAR decreases each year by -8.80%.
Dividend Growth(5Y)-8.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

YAR pays out 41.38% of its income as dividend. This is a bit on the high side, but may be sustainable.
The Dividend Rate of YAR has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP41.38%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
YAR.OL Yearly Income VS Free CF VS DividendYAR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
YAR.OL Dividend Payout.YAR.OL Dividend Payout, showing the Payout Ratio.YAR.OL Dividend Payout.PayoutRetained Earnings

YARA INTERNATIONAL ASA

OSL:YAR (7/11/2025, 7:00:00 PM)

385

-3.2 (-0.82%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-18 2025-07-18/bmo
Inst Owners42.41%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap98.07B
Analysts65.19
Price Target368.9 (-4.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend4.74
Dividend Growth(5Y)-8.8%
DP41.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.75%
Min EPS beat(2)-47.21%
Max EPS beat(2)37.7%
EPS beat(4)3
Avg EPS beat(4)19.35%
Min EPS beat(4)-47.21%
Max EPS beat(4)50.14%
EPS beat(8)4
Avg EPS beat(8)40.78%
EPS beat(12)6
Avg EPS beat(12)23.78%
EPS beat(16)7
Avg EPS beat(16)11.92%
Revenue beat(2)1
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-3.34%
Max Revenue beat(2)0.19%
Revenue beat(4)1
Avg Revenue beat(4)-2.83%
Min Revenue beat(4)-4.86%
Max Revenue beat(4)0.19%
Revenue beat(8)1
Avg Revenue beat(8)-8.1%
Revenue beat(12)2
Avg Revenue beat(12)-4.97%
Revenue beat(16)4
Avg Revenue beat(16)-3.46%
PT rev (1m)1.97%
PT rev (3m)3.32%
EPS NQ rev (1m)7.46%
EPS NQ rev (3m)25.15%
EPS NY rev (1m)0%
EPS NY rev (3m)0.56%
Revenue NQ rev (1m)2.05%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.48%
Valuation
Industry RankSector Rank
PE 15.1
Fwd PE 12.03
P/S 0.69
P/FCF 20.83
P/OCF 6.24
P/B 1.3
P/tB 1.46
EV/EBITDA 6.23
EPS(TTM)25.5
EY6.62%
EPS(NY)31.99
Fwd EY8.31%
FCF(TTM)18.48
FCFY4.8%
OCF(TTM)61.65
OCFY16.01%
SpS560.94
BVpS297.07
TBVpS263.63
PEG (NY)0.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.85%
ROE 3.86%
ROCE 8.99%
ROIC 6.87%
ROICexc 7.05%
ROICexgc 7.58%
OM 7.91%
PM (TTM) 2.05%
GM 27.32%
FCFM 3.29%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
ROICexc(3y)11.17%
ROICexc(5y)10.65%
ROICexgc(3y)12.02%
ROICexgc(5y)11.5%
ROCE(3y)13.48%
ROCE(5y)12.99%
ROICexcg growth 3Y-20.87%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-20.66%
ROICexc growth 5Y0.45%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 8.76
Debt/EBITDA 1.8
Cap/Depr 104.6%
Cap/Sales 7.7%
Interest Coverage 4.23
Cash Conversion 72%
Profit Quality 161.03%
Current Ratio 1.9
Quick Ratio 0.96
Altman-Z 2.75
F-Score6
WACC8.49%
ROIC/WACC0.81
Cap/Depr(3y)107.36%
Cap/Depr(5y)98.34%
Cap/Sales(3y)6.55%
Cap/Sales(5y)6.27%
Profit Quality(3y)1242.99%
Profit Quality(5y)807.54%
High Growth Momentum
Growth
EPS 1Y (TTM)175%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%380.95%
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-11.73%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%10.55%
Revenue Next Year6.33%
Revenue Next 2Y2.5%
Revenue Next 3Y2.43%
Revenue Next 5Y2.71%
EBIT growth 1Y140.56%
EBIT growth 3Y-20.82%
EBIT growth 5Y-2.34%
EBIT Next Year149.37%
EBIT Next 3Y35.87%
EBIT Next 5Y12.96%
FCF growth 1Y-69.97%
FCF growth 3Y-28.42%
FCF growth 5Y-24.89%
OCF growth 1Y-39.59%
OCF growth 3Y-2.93%
OCF growth 5Y-7.58%